Top compounds associated with response to SERINC4


Feature Type Standardized
Nominal ANOVA
mRNA ELCPK CTRPv2 pan-cancer AAC 0.13 0.01
mRNA Erlotinib gCSI pan-cancer AAC -0.16 0.01
mRNA RITA CTRPv2 pan-cancer AAC 0.09 0.02
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.02
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC 0.14 0.02
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.02
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.02
mRNA lovastatin CTRPv2 pan-cancer AAC -0.091 0.02
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA PDMP CTRPv2 pan-cancer AAC 0.092 0.02
Download CSV